MSMargaret B. Swift

Margaret B. Swift

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Margaret B. Swift has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vivo spatial coordination with synthetic paracrine signaling

    by Kaiwen Luo, Yitong Ma, Hongyi R. Li, Hengyu Li, Margaret B. Swift, Nathan F. Dalleska, Abdullah S. Farooq, Ernesto Criado-Hidalgo, Ann Liu, Mikhail G. Shapiro, et al.

    The immune system uses paracrine signaling to spatially confine potent responses such as inflammation. A bio-orthogonal synthetic paracrine system could enable engineering of analogous multicellular circuits in which different cell types coordinate their functions in a spatially organized fashion. Here, using the plant hormone auxin as a bio-orthogonal chemical signal, we introduce programmable paracrine circuits that distribute sensing and effector functions to different cell types to spatially restrict responses in mouse xenografts. Cells engineered to express auxin biosynthetic genes generated auxin-dense regions with tunable length scales in vivo. This localized signaling ability enabled design of a multicellular sentinel-effector system, in which THP-1 sentinel cells conditionally produce auxin in regions expressing the tumor-specific antigen EGFRvIII, and Jurkat effector cells respond by locally modulating the activity of a chimeric antigen receptor (CAR). This two-cell type system was able to achieve localized activation of engineered effector cells in vivo. These results establish a foundation for engineering multicellular therapeutic systems that focus responses in specific tissue contexts or disease sites.

  • Open Access

    Non-invasive imaging of cell-based therapies using acoustic reporter genes

    by Shirin Shivaei, Ann Liu, Mohamad H. Abedi, Julio Revilla, Isabella U. Hurvitz, Margaret B. Swift, Mikhail G. Shapiro

    Cell-based therapies are a major emerging category of medicine. The ability of engineered cells to traffic to and function at specific anatomical locations is a major aspect of their performance. However, there is a lack of non-invasive, non-ionizing, cost-accessible methods to track these therapies inside the body and ensure proper function. Here, we establish a platform for in vivo imaging of primary cell therapies using ultrasound – a ubiquitously accessible technology for high-resolution non-invasive imaging. We introduce and optimize a lentiviral delivery system to express acoustic reporter genes based on gas vesicles in primary mammalian cells such as T cells, showing that this results in robust ultrasound contrast. Additionally, we develop genetic circuits making it possible to monitor T cell activation via activity-dependent promoters. We apply this technology to primary human T cells, using it to non-invasively track their accumulation and proliferation as a targeted therapy in a mouse tumor xenograft model and compare it to invasive, terminal measures such as immunohistology. By making it possible to visualize cell-based therapies and their function inside opaque living organs with unprecedented resolution and accessibility, this technology has the potential to significantly accelerate their development and effective use.


  • Open Access

    Multiplexed Ultrasound Imaging of Gene Expression

    by Nivin N. Nyström, Zhiyang Jin, Marisa E. Bennett, Ruby Zhang, Margaret B. Swift, Mikhail G. Shapiro

    Acoustic reporter genes (ARGs) have enabled the imaging of gene expression with ultrasound, which provides high-resolution access to deep, optically opaque living tissues. However, unlike their fluorescent counterparts, ARGs have so far been limited to a single “color,” preventing multiplexed imaging of cellular states or populations. Here, we use rational protein design and directed evolution to develop two novel ARGs that can be distinguished from each other based on their acoustic pressure response profiles, enabling “two-color” ultrasound imaging of gene expression. We demonstrate the utility of multiplexed ARGs for delineating bacterial cell species and cell states in vitro , and then apply them towards imaging distinct subpopulations of probiotics in the mouse gastrointestinal tract and in tumor-colonizing bacterial agents in vivo . Just as the first wavelength-shifted derivatives of fluorescent proteins opened a vivid world for optical microscopy, our next-generation acoustic proteins set the stage for a richer symphony of ultrasound signals from living subjects.


  • Open Access

    Truly Tiny Acoustic Biomolecules for Ultrasound Imaging and Therapy

    by Bill Ling, Bilge Gungoren, Yuxing Yao, Przemysław Dutka, Reid Vassallo, Rohit Nayak, Cameron A. B. Smith, Justin Lee, Margaret B. Swift, Mikhail G. Shapiro

    Nanotechnology offers significant advantages for medical imaging and therapy, including enhanced contrast and precision targeting. However, integrating these benefits into ultrasonography is challenging due to the size and stability constraints of conventional bubble‐based agents. Here bicones, truly tiny acoustic contrast agents based on gas vesicles (GVs), a unique class of air‐filled protein nanostructures naturally produced in buoyant microbes, are described. It is shown that these sub‐80 nm particles can be effectively detected both in vitro and in vivo, infiltrate tumors via leaky vasculature, deliver potent mechanical effects through ultrasound‐induced inertial cavitation, and are easily engineered for molecular targeting, prolonged circulation time, and payload conjugation.


  • Open Access

    Gas vesicle-blood interactions enhance ultrasound imaging contrast

    by Bill Ling, Jeong Hoon Ko, Benjamin Stordy, Yuwei Zhang, Tighe F. Didden, Dina Malounda, Margaret B. Swift, Warren C.W. Chan, Mikhail G. Shapiro

    Gas vesicles (GVs) are genetically encoded, air-filled protein nanostructures of broad interest for biomedical research and clinical applications, acting as imaging and therapeutic agents for ultrasound, magnetic resonance, and optical techniques. However, the biomedical applications of GVs as a systemically injectable nanomaterial have been hindered by a lack of understanding of GVs’ interactions with blood components, which can significantly impact in vivo performance. Here, we investigate the dynamics of GVs in the bloodstream using a combination of ultrasound and optical imaging, surface functionalization, flow cytometry, and mass spectrometry. We find that erythrocytes and serum proteins bind to GVs and shape their acoustic response, circulation time, and immunogenicity. We show that by modifying the GV surface, we can alter these interactions and thereby modify GVs’ in vivo performance. These results provide critical insights for the development of GVs as agents for nanomedicine.


  • Open Access

    Truly tiny acoustic biomolecules for ultrasound imaging and therapy

    by Bill Ling, Bilge Gungoren, Yuxing Yao, Przemysław Dutka, Cameron A. B. Smith, Justin Lee, Margaret B. Swift, Mikhail G. Shapiro

    Nanotechnology offers significant advantages for medical imaging and therapy, including enhanced contrast and precision targeting. However, integrating these benefits into ultrasonography has been challenging due to the size and stability constraints of conventional bubble-based agents. Here we describe bicones, truly tiny acoustic contrast agents based on gas vesicles, a unique class of air-filled protein nanostructures naturally produced in buoyant microbes. We show that these sub-80 nm particles can be effectively detected both in vitro and in vivo, infiltrate tumors via leaky vasculature, deliver potent mechanical effects through ultrasound-induced inertial cavitation, and are easily engineered for molecular targeting, prolonged circulation time, and payload conjugation.


  • Open Access

    Genomically mined acoustic reporter genes enable real-time in vivo monitoring of tumors and tumor-homing probiotics

    by Robert C. Hurt, Marjorie T. Buss, Mengtong Duan, Katie Wong, Mei Yi You, Daniel P. Sawyer, Margaret B. Swift, Przemysław Dutka, Pierina Barturen-Larrea, David R. Mittelstein, et al.

    A major outstanding challenge in the fields of biological research, synthetic biology and cell-based medicine is visualizing the function of natural and engineered cells noninvasively inside opaque organisms. Ultrasound imaging has the potential to address this challenge as a widely available technique with a tissue penetration of several centimeters and spatial resolution below 100 μm. Recently, the first genetically encoded acoustic reporters were developed based on bacterial gas vesicles to link ultrasound signals to molecular and cellular function. However, the properties of these first-generation acoustic reporter genes (ARGs) resulted in limited sensitivity and specificity for imaging gene expression in vivo. Here, we describe second-generation ARGs with greatly improved acoustic properties and expression characteristics, identified through a phylogenetic screen of candidate gene clusters from diverse bacteria and archaea. The resulting constructs offer major qualitative and quantitative improvements, including much stronger ultrasound contrast, the ability to produce nonlinear signals distinguishable from background tissue, and stable long-term expression. We demonstrate the capabilities of these next-generation ARGs by imaging in situ gene expression in mouse models of breast cancer and tumor-homing therapeutic bacteria, noninvasively revealing the unique spatial distributions of tumor growth and colonization by therapeutic cells in living subjects and providing real-time guidance for interventions such as needle biopsies.


  • Open Access

    Acoustic Remote Control of Bacterial Immunotherapy

    by Mohamad H. Abedi, Michael S. Yao, David R. Mittelstein, Avinoam Bar-Zion, Margaret Swift, Audrey Lee-Gosselin, Mikhail G. Shapiro

    Rapid advances in synthetic biology are driving the development of genetically engineered microbes as therapeutic agents for a multitude of human diseases, including cancer. In particular, the immunosuppressive microenvironment of solid tumors creates a favorable niche for systemically administered bacteria to engraft in the tumor and release therapeutic payloads. However, such payloads can be harmful if released in healthy tissues where the bacteria also engraft in smaller numbers. To address this limitation, we engineer therapeutic bacteria to be controlled by focused ultrasound, a form of energy that can be applied noninvasively to specific anatomical sites such as solid tumors. This control is provided by a temperature-actuated genetic state switch that produces lasting therapeutic output in response to briefly applied focused ultrasound hyperthermia. Using a combination of rational design and high-throughput screening we optimized the switching circuits of engineered cells and connected their activity to the release of immune checkpoint inhibitors. In a clinically relevant cancer model, ultrasound-activated therapeutic microbes successfully turned on in situ and induced a marked suppression of tumor growth. This technology provides a critical tool for the spatiotemporal targeting of potent bacterial therapeutics in a variety of biological and clinical scenarios.